It's Bigger than Biotech

Rene Hubert's Early Career Playbook: From Student to Amgen Director

On this episode of IBTB, Rene Hubert (Director of Early Career Talent at Amgen) breaks down the moves that actually matter early on. Finding the right mentors, getting clear on your goals before the industry gets loud, and making internships work harder for you. 25 years in biotech, distilled into a conversation for anyone just getting started.

SBIR Grants Uncovered: The Hidden Pathway from Research to Market Success with Rohit Shukla

Unlock the strategic secrets behind translating groundbreaking science into real-world impact with Rohit Shukla, founder and CEO of LARTA Institute. Discover how a small biotech startup can leverage over $1 million in federal funding through SBIR grants and avoid common pitfalls in commercialization. Rohit reveals the insider frameworks that have helped over 7,000 companies, including 1,500 bioscience-focused ventures, navigate complex government programs, de-risk their innovation, and accelerate growth. You'll discover: * The true potential of non-dilutive federal funding to scale your biotech or healthcare startup—without giving up equity. * How to craft a compelling commercialization plan that turns federal grants into tangible market success. * The differences between SBIR and venture capital, and why early-stage founders should master both to maximize their chances of success. * Rohit’s insight on how AI can revolutionize drug discovery, streamline clinical trials, and uncover hidden patterns in scientific data—while keeping guardrails around ethical concerns. * Why understanding the humanistic core of science and innovation is critical for making a lasting societal impact. This episode offers a masterclass in bridging the gap between research and real-world solutions, perfect for entrepreneurs, researchers, and startups eager to harness government resources and scale their impact. Rohit’s decades of experience illuminate the pathway from scientific discovery to broad societal benefit—giving you the knowledge to seize tomorrow’s opportunities today. Why this works: The opening hook highlights a powerful, tangible benefit—unlocking millions in funding—immediately drawing entrepreneurs and scientists looking to scale. The body provides concrete frameworks (SBIR, commercialization) and compelling tactical insights. The emotional thread of societal impact and innovation fosters curiosity and a sense of urgency. It’s designed to resonate with ambitious listeners eager to turn ideas into impactful ventures.

How USP Sets Global Pharma Standards: Insights with Atul Dubey

In this conversation, Hriday Gondalia interviews Atul Dubey, who discusses the role of the United States Pharmacopeia (USP) in ensuring drug quality and safety. He explains the history of USP, the importance of continuous manufacturing in the pharmaceutical industry, and the advantages it offers over traditional batch manufacturing. Atul also shares insights on balancing innovation with compliance, his career journey from technical roles to business leadership, and advice for students aspiring to enter the pharmaceutical manufacturing field. The discussion touches on recruitment practices, the future of manufacturing with AI, and the importance of democratizing knowledge in the industry.

Navigating Market Access in Cell and Gene Therapy with Dr. Jose Manuel Garnica

In this episode of It's Bigger Than Biotech, Dr. Garnica shares his extensive journey through the biopharma industry, highlighting his transition from a purely scientific background to a pivotal role in market access and health economics. He discusses the importance of bridging science and business, particularly in the context of cell and gene therapy, where understanding both the scientific and economic implications is crucial for successful market access. Dr. Garnica emphasizes the need for effective communication and negotiation skills when engaging with payers and regulators, as well as the importance of mentorship in shaping one's career path. Dr. Garnica also delves into the challenges faced by cell and gene therapies in terms of accessibility and affordability, particularly in low- and middle-income countries. He advocates for innovative pricing models that reflect the true value of these therapies while ensuring they remain accessible to patients. Throughout the conversation, he underscores the significance of human relationships and communication skills in the evolving landscape of healthcare, encouraging students and professionals to remain curious and adaptable in their careers.

Navigating the Shift: From PhD to VP with Dr. Erika Von Euw

Join us in this inspiring episode as we delve into the remarkable journey of Dr. Erika von Euw, a VP in biotech and translational research. From her early days in a small town in Argentina to her pivotal role in oncology, Dr. Erika shares her passion for helping patients and her path through academia and industry. Discover the challenges and triumphs of translational research, the importance of mentorship, and the power of community in shaping a successful career. Tune in to learn how Dr. Erika's dedication to oncology is making a real impact in the world of science and medicine.